Lumida
/SSRI
⌘K
SSRI

SSRI

SSRI
$9.56USD-1.54%-0.15 today

MARKET CAP

0

P/E (TTM)

FWD P/E

DAY RANGE

$10 – $10

52W RANGE

$8
$16
STATEMENT·Income statement
USD · GAAP
METRICFY 2012FY 2013FY 2014FY 2015FY 2016TREND
Sales, Adj.$241.1M$174.7M$300.1M$375.3M$491.0M
YoY %+162989.7%-27.6%+71.8%+25.1%+30.8%
P / Sales
EV / Sales
Gross Profit, Adj.$58.1M$5.2M$36.2M$18.8M$154.0M
YoY %+111814.7%-91.1%+598.3%-48.0%+717.4%
Margin %24.1%3.0%12.1%5.0%31.4%
EV / Gross Profit
EBITDA, Adj.$65.2M$1.3M$35.5M$57.3M$193.5M
YoY %+131619.5%-98.0%+2596.5%+61.7%+237.5%
Margin %27.0%0.8%11.8%15.3%39.4%
EV / EBITDA
EBIT$21.7M$-244.2M$-52.5M$-71.1M$112.6M
YoY %+96248.3%-1223.0%+78.5%-35.4%+258.5%
Margin %9.0%-139.8%-17.5%-18.9%22.9%
EV / EBIT
Net Income$55.3M$-230.0M$-126.4M$-124.3M$65.0M
YoY %+68949.5%-515.7%+45.1%+1.7%+152.3%
Net Margin22.9%-131.7%-42.1%-33.1%13.2%
EPS (GAAP)$0.69-$2.85-$1.57-$1.54$0.62
YoY %-30.3%-513.0%+44.9%+1.9%+140.3%